UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’
Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus.
The UK vaccines taskforce has bought 60m doses of the Novavax vaccine, one of seven in its portfolio, and it will be manufactured on Teesside in the UK. If it is given emergency authorisation by the UK regulator, it could boost the country’s immunisation programme and solve the potential problems over the supply of the other two vaccines in use.
